1
|
Ullah A, Jiao W, Shen B. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management. Cell Mol Biol Lett 2024; 29:73. [PMID: 38745115 PMCID: PMC11094955 DOI: 10.1186/s11658-024-00591-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 05/06/2024] [Indexed: 05/16/2024] Open
Abstract
Reproductive cancers are malignancies that develop in the reproductive organs. One of the leading cancers affecting the male reproductive system on a global scale is prostate cancer (PCa). The negative consequences of PCa metastases endure and are severe, significantly affecting mortality and life quality for those who are affected. The association between inflammation and PCa has captured interest for a while. Inflammatory cells, cytokines, CXC chemokines, signaling pathways, and other elements make up the tumor microenvironment (TME), which is characterized by inflammation. Inflammatory cytokines and CXC chemokines are especially crucial for PCa development and prognosis. Cytokines (interleukins) and CXC chemokines such as IL-1, IL-6, IL-7, IL-17, TGF-β, TNF-α, CXCL1-CXCL6, and CXCL8-CXCL16 are thought to be responsible for the pleiotropic effects of PCa, which include inflammation, progression, angiogenesis, leukocyte infiltration in advanced PCa, and therapeutic resistance. The inflammatory cytokine and CXC chemokines systems are also promising candidates for PCa suppression and immunotherapy. Therefore, the purpose of this work is to provide insight on how the spectra of inflammatory cytokines and CXC chemokines evolve as PCa develops and spreads. We also discussed recent developments in our awareness of the diverse molecular signaling pathways of these circulating cytokines and CXC chemokines, as well as their associated receptors, which may one day serve as PCa-targeted therapies. Moreover, the current status and potential of theranostic PCa therapies based on cytokines, CXC chemokines, and CXC receptors (CXCRs) are examined.
Collapse
Affiliation(s)
- Amin Ullah
- Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| | - Wang Jiao
- Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
| | - Bairong Shen
- Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
| |
Collapse
|
2
|
Xu H, Wu C, Wang D, Wang H. Alleviating effect of Nexrutine on mucosal inflammation in mice with ulcerative colitis: Involvement of the RELA suppression. Immun Inflamm Dis 2024; 12:e1147. [PMID: 38270298 PMCID: PMC10797652 DOI: 10.1002/iid3.1147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Revised: 12/27/2023] [Accepted: 12/28/2023] [Indexed: 01/26/2024] Open
Abstract
BACKGROUND Nexrutine is an herbal extract derived from Phellodendron amurense, known for its anti-inflammatory, antidiarrheal, and hemostatic properties. However, its effect on ulcerative colitis (UC) remains unclear. METHODS A mouse model of UC was induced by 3% dextran sulfate sodium, while human colonic epithelial cells NCM-460 were exposed to lipopolysaccharide. Both models were treated with Nexrutine at 300 or 600 mg/kg, with Mesalazine applied as a positive control regimen. The disease activity index (DAI) of mice was calculated, and the pathological injury scores were assessed through hematoxylin and eosin staining. The viability of NCM-460 cells was determined using the CCK-8 method. Inflammatory cytokines were detected using ELISA kits. Expression of mucin 3 (MUC3), Claudin-1, and tight junction protein (ZO-1) was detected to analyze mucosal barrier integrity. Target genes of Nexrutine were predicted using bioinformatics tools. Expression of RELA proto-oncogene (RELA) was analyzed using qPCR and western blot assays. RESULTS The Nexrutine treatments significantly alleviated DAI of mice, mitigated pathological changes in their colon tissues, decreased the production of pro-inflammatory cytokines, enhanced the barrier integrity-related proteins, and increased NCM-460 cell viability in vitro. RELA, identified as a target gene of Nexrutine, showed elevated levels in UC models but was substantially suppressed by Nexrutine treatment. Adenovirus-mediated RELA upregulation in mice or the overexpression plasmid of RELA in cells counteracted the effects of Nexrutine treatments, exacerbating UC-related symptoms. CONCLUSION This study demonstrates that Nexrutine alleviates inflammatory mucosal barrier damage in UC by suppressing RELA transcription.
Collapse
Affiliation(s)
- Hongyun Xu
- Graduate SchoolHeilongjiang University of Chinese MedicineHarbinHeilongjiangChina
| | - Chunyu Wu
- Department of Continuing EducationFirst Affiliated Hospital of Heilongjiang University of Chinese MedicineHarbinHeilongjiangChina
| | - Danning Wang
- Graduate SchoolHeilongjiang University of Chinese MedicineHarbinHeilongjiangChina
| | - Haiqiang Wang
- Department of Liver, Spleen and StomachFirst Affiliated Hospital of Heilongjiang University of Chinese MedicineHarbinHeilongjiangChina
| |
Collapse
|
3
|
Therapeutic yoga reduces pro-tumorigenic cytokines in cancer survivors. Support Care Cancer 2023; 31:33. [PMID: 36517621 PMCID: PMC9750838 DOI: 10.1007/s00520-022-07536-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Accepted: 12/09/2022] [Indexed: 12/23/2022]
Abstract
INTRODUCTION Chronic inflammation can remain many years after the completion of cancer treatment and is associated with cancer recurrence. The purpose of this study was to examine how a 16-week therapeutic yoga program (TYP) modulates the cytokine profile in heterogeneous cancer survivors. METHODS Eligible participants were 18 years of age or older and clinically diagnosed with cancer. Consenting participants were asked to attend three, 75-min sessions weekly of TYP with meditation. Seventeen patients provided blood samples at baseline and end of study. Eight cytokines (interferon (IFN)-γ; interleukin (IL)-1b, IL-1ra, IL-4, IL-6, IL-8, IL-10; and tumor necrosis factor (TNF)-α), three receptors (sIL-6R, sTNFRI, sTNFRII), and C-reactive protein (CRP) were quantified. RESULTS Patients were 59.6 ± 7.3 years old; over half (56%) were overweight or obese BMI ≥ 25 kg/m2); majority were female (71%) and breast cancer survivors (65%), of which 44% were Hispanic. Marked reductions were observed in all cytokines except IL-4, with significant reductions (p < 0.05) found in IL-1b (- 13%) and IL-1ra (- 13%). No significant changes were observed in soluble cytokine receptors or CRP. CONCLUSIONS TYP led to significant reduction in circulating cytokines associated with chronic inflammation in a heterogeneous sample of cancer survivors.
Collapse
|
4
|
Moon C, Gallegos AM, Sheikh B, Kumar P, Liss M, Patel DI. Pilot Study on the Impact of a Home-Based Exercise Program on Inflammatory Cytokines and Quality of Life in Men with Prostate Cancer Under Active Surveillance. Cancer Control 2022; 29:10732748221130964. [PMID: 36200522 PMCID: PMC9549098 DOI: 10.1177/10732748221130964] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVES This study aimed to demonstrate potential translation of pre-clinical studies to a home-based exercise intervention in mediating inflammatory cytokine markers and tumor progression in men under active surveillance for prostate cancer. METHODS A 2-arm randomized control parallel group design was used. The exercise intervention consisted of 24 weeks of an aerobic and resistance home-based exercise program and results were compared to a waitlist control group. Data were collected at baseline and end of study for eotaxin, interferon-γ (INF-γ), interleukin-12 (IL-12), interleukin-1α (IL-1α), interleukin-5 (IL-5), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and vascular endothelial growth factor (VEGF), distanced walked during a 6-minute walk test (6MWT), body mass index, and health-related quality of life. RESULTS Non-significant decreases were observed in all biomarkers, especially VEGF (pre: 125.16 ± 198.66, post: 80.29 ± 124.30, P = .06) and INF-γ (pre: 152.88 ± 312.71, post: 118.93 ± 158.79, P = .08), in the intervention group; only IL- α (pre: 332.15 ± 656.77, post: 255.12 ± 502.09, P = .20) decreased in the control group while all other biomarkers increased from baseline to end of study. A non-significant increase in 6MWT distance was observed in the intervention group, while a decrease was seen in the control group. Significant decreases in physical function, emotional wellbeing, and total composite scale on the FACIT-F were observed in the intervention group, possibly due to the isolation restrictions of COVID-19. Physical function on the SF-36 significantly increased in the control group. CONCLUSIONS Future studies with powered samples are needed to confirm the trends observed for inflammatory biomarkers and functional fitness.
Collapse
Affiliation(s)
- Crisann Moon
- Biobehavioral Laboratory, School of
Nursing, UT Health San Antonio, San Antonio, TX, USA
| | - Amber M. Gallegos
- Biobehavioral Laboratory, School of
Nursing, UT Health San Antonio, San Antonio, TX, USA
| | - Bilal Sheikh
- Biobehavioral Laboratory, School of
Nursing, UT Health San Antonio, San Antonio, TX, USA
| | - Pratap Kumar
- School of Medicine, UT Health San Antonio, San Antonio, TX, USA,Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA
| | - Michael Liss
- School of Medicine, UT Health San Antonio, San Antonio, TX, USA,Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA
| | - Darpan I. Patel
- Biobehavioral Laboratory, School of
Nursing, UT Health San Antonio, San Antonio, TX, USA,Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA,Barshop Institute for Longevity and
Aging Studies, UT Health San Antonio, San Antonio, TX, USA,Darpan I. Patel, The University of Texas
Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229,
USA.
| |
Collapse
|
5
|
Zhou L, Zhang Z, Nice E, Huang C, Zhang W, Tang Y. Circadian rhythms and cancers: the intrinsic links and therapeutic potentials. J Hematol Oncol 2022; 15:21. [PMID: 35246220 PMCID: PMC8896306 DOI: 10.1186/s13045-022-01238-y] [Citation(s) in RCA: 24] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2021] [Accepted: 02/16/2022] [Indexed: 02/07/2023] Open
Abstract
The circadian rhythm is an evolutionarily conserved time-keeping system that comprises a wide variety of processes including sleep-wake cycles, eating-fasting cycles, and activity-rest cycles, coordinating the behavior and physiology of all organs for whole-body homeostasis. Acute disruption of circadian rhythm may lead to transient discomfort, whereas long-term irregular circadian rhythm will result in the dysfunction of the organism, therefore increasing the risks of numerous diseases especially cancers. Indeed, both epidemiological and experimental evidence has demonstrated the intrinsic link between dysregulated circadian rhythm and cancer. Accordingly, a rapidly increasing understanding of the molecular mechanisms of circadian rhythms is opening new options for cancer therapy, possibly by modulating the circadian clock. In this review, we first describe the general regulators of circadian rhythms and their functions on cancer. In addition, we provide insights into the mechanisms underlying how several types of disruption of the circadian rhythm (including sleep-wake, eating-fasting, and activity-rest) can drive cancer progression, which may expand our understanding of cancer development from the clock perspective. Moreover, we also summarize the potential applications of modulating circadian rhythms for cancer treatment, which may provide an optional therapeutic strategy for cancer patients.
Collapse
Affiliation(s)
- Li Zhou
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China
| | - Zhe Zhang
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China
| | - Edouard Nice
- Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, 3800, Australia
| | - Canhua Huang
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Sciences and Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China. .,School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
| | - Wei Zhang
- Mental Health Center and Psychiatric Laboratory, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. .,West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
| | - Yong Tang
- Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Acupuncture and Chronobiology Laboratory of Sichuan Province, Chengdu, 610075, China.
| |
Collapse
|
6
|
Dufresne S, Richard C, Dieumegard A, Orfila L, Delpon G, Chiavassa S, Martin B, Rouvière L, Escoffre JM, Oujagir E, Denis de Senneville B, Bouakaz A, Rioux-Leclercq N, Potiron V, Rébillard A. Voluntary Wheel Running Does Not Enhance Radiotherapy Efficiency in a Preclinical Model of Prostate Cancer: The Importance of Physical Activity Modalities? Cancers (Basel) 2021; 13:cancers13215402. [PMID: 34771565 PMCID: PMC8582584 DOI: 10.3390/cancers13215402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 10/21/2021] [Accepted: 10/21/2021] [Indexed: 11/16/2022] Open
Abstract
Physical activity is increasingly recognized as a strategy able to improve cancer patient outcome, and its potential to enhance treatment response is promising, despite being unclear. In our study we used a preclinical model of prostate cancer to investigate whether voluntary wheel running (VWR) could improve tumor perfusion and enhance radiotherapy (RT) efficiency. Nude athymic mice were injected with PC-3 cancer cells and either remained inactive or were housed with running wheels. Apparent microbubble transport was enhanced with VWR, which we hypothesized could improve the RT response. When repeating the experiments and adding RT, however, we observed that VWR did not influence RT efficiency. These findings contrasted with previous results and prompted us to evaluate if the lack of effects observed on tumor growth could be attributable to the physical activity modality used. Using PC-3 and PPC-1 xenografts, we randomized mice to either inactive controls, VWR, or treadmill running (TR). In both models, TR (but not VWR) slowed down tumor growth, suggesting that the anti-cancer effects of physical activity are dependent on its modalities. Providing a better understanding of which activity type should be recommended to cancer patients thus appears essential to improve treatment outcomes.
Collapse
Affiliation(s)
- Suzanne Dufresne
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
| | - Cindy Richard
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
| | - Arthur Dieumegard
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
| | - Luz Orfila
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
| | - Gregory Delpon
- Centre René Gauducheau, Institut de Cancérologie de l’Ouest, F-44805 Saint Herblain, France; (G.D.); (S.C.)
| | - Sophie Chiavassa
- Centre René Gauducheau, Institut de Cancérologie de l’Ouest, F-44805 Saint Herblain, France; (G.D.); (S.C.)
| | - Brice Martin
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
| | - Laurent Rouvière
- IRMAR-UMR CNRS 6625, University of Rennes, F-35000 Rennes, France; (L.R.); (V.P.)
| | - Jean-Michel Escoffre
- UMR 1253, iBrain, INSERM, Université de Tours, F-37032 Tours, France; (J.-M.E.); (E.O.); (A.B.)
| | - Edward Oujagir
- UMR 1253, iBrain, INSERM, Université de Tours, F-37032 Tours, France; (J.-M.E.); (E.O.); (A.B.)
| | | | - Ayache Bouakaz
- UMR 1253, iBrain, INSERM, Université de Tours, F-37032 Tours, France; (J.-M.E.); (E.O.); (A.B.)
| | - Nathalie Rioux-Leclercq
- Department of Pathological Anatomy and Cytology, Université Rennes 1, F-35000 Rennes, France;
| | - Vincent Potiron
- IRMAR-UMR CNRS 6625, University of Rennes, F-35000 Rennes, France; (L.R.); (V.P.)
- LaBCT, CRCINA INSERM U1232, Université de Nantes, Université d’Angers, F-44000 Nantes, France
| | - Amélie Rébillard
- Movement, Sport and Health Sciences Laboratory (M2S)-EA7470, University of Rennes, F-35000 Rennes, France; (S.D.); (C.R.); (A.D.); (L.O.); (B.M.)
- Institut Universitaire de France (IUF), F-75231 Paris, France
- Correspondence: ; Tel.: +33-29-009-1587
| |
Collapse
|